Home/Filings/4/0001567619-21-018628
4//SEC Filing

SCHAFFER DAVID 4

Accession 0001567619-21-018628

CIK 0001650648other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 9:42 PM ET

Size

9.3 KB

Accession

0001567619-21-018628

Insider Transaction Report

Form 4
Period: 2021-10-20
SCHAFFER DAVID
Director10% Owner
Transactions
  • Sale

    Common Stock

    2021-10-22$31.00/sh1,900$58,893901,215 total
  • Sale

    Common Stock

    2021-10-21$31.56/sh22,820$720,156903,115 total
  • Sale

    Common Stock

    2021-10-20$31.02/sh11,565$358,771925,935 total
Footnotes (4)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $30.27 to $32.07,inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The transaction was executed in multiple trades in prices ranging from $30.70 to $32.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]The transaction was executed in multiple trades in prices ranging from $30.76 to $31.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

4D Molecular Therapeutics Inc.

CIK 0001650648

Entity typeother

Related Parties

1
  • filerCIK 0001692929

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 9:42 PM ET
Size
9.3 KB